Eyegenex
Glaucoma is the leading cause of blindness and is often related to high intraocular pressure. However, over 10% have progressive visual loss despite optimal intraocular pressure lowering. Our drugs are proven to reduce visual loss in animal studies. Non-human primate studies are pending, and human trials will begin in 2025. Diabetic Retinopathy (DR) is caused by damage to blood vessels in the retina of diabetic patients leading to vision loss. Our DR therapeutics are in the early stages of pre-clinical studies
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Eyegenex
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
Showing 1 of 3 verified contacts
Top roles at Eyegenex
2 distinct titles indexed · top 2 shown.
- 1chief medical advisor
- 1pegasus angel accelerator
Sign up to unlock all 3 contacts at Eyegenex
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Eyegenex
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.